Aethlon Medical Discloses Live Webcast of Today's BIOCOM Presentation

Monday, October 26, 2009 General News
Email Print This Page Comment
Font : A-A+



SAN DIEGO, Oct. 26 Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) disclosed that today's presentation at the 4th Annual BIOCOM Investor Conference will be webcast live today. The presentation by Aethlon Chairman and CEO, James A. Joyce will begin at 2 p.m. pacific time and can be accessed on an audio-only basis at:

http://www.biocom.org/event/2009_Investor_Conference

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

About BIOCOM

BIOCOM is the largest regional life science association in the world, representing 550 member companies in Southern California. The association focuses on initiatives that position the region's life science industry competitively on the world stage, and on the development and delivery of innovative products that improve health and quality of life. This includes initiatives in capital formation, public policy, workforce development, and member services. For more information on BIOCOM or the Southern California biotechnology and medical device community, please visit the organization's website at http://www.biocom.org.

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our HemopurifierŪ represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The HemopurifierŪ seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

Contacts: RedChip Companies, Inc. Jon Cunningham 1-800-733-2447, Ext. 107 Jon@redchip.com Jim Joyce Chairman, CEO 858.459.7800 x301 jj@aethlonmedical.com Jim Frakes Senior VP Finance 858.459.7800 x300 jfrakes@aethlonmedical.com

SOURCE Aethlon Medical, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook